Biotech Insider – Insider News From The Biotech World

Measles cases — and misinformation — on the rise

Trending Now April 24, 2025 By News Team
Help for ACA health plans could be harder to come by since RFK axed teams of ‘fixers’

Trending Now April 24, 2025 By News Team
Psychedelics May Reverse Effects of Neuroimmune Interactions That Drive Fear Responses

Biotechnology Daily April 24, 2025 By News Team

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Biotechnology Daily April 24, 2025 By News Team

Swiss ADC Biotech Takes SPAC Track to NASDAQ

Bio Business News April 24, 2025 By News Team

Pharma’s Biggest Golden Parachutes

Bio Business News April 24, 2025 By News Team

In The News

Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By Editor
UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By Editor
Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By Editor

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Measles cases — and misinformation — on the rise

Help for ACA health plans could be harder to come by since RFK axed teams of ‘fixers’

Psychedelics May Reverse Effects of Neuroimmune Interactions That Drive Fear Responses

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

Swiss ADC Biotech Takes SPAC Track to NASDAQ

Pharma’s Biggest Golden Parachutes

In The News

Biotechnology Daily

Psychedelics May Reverse Effects of Neuroimmune Interactions That Drive Fear Responses

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation

EditCo, Promega to Combine CRISPR Knock-In Capabilities with Protein-Labeling Tech

Electricity-conducting organism named after Native American Tribe may advance bioelectronic devices

Tempest Cuts 80% of Staff While Considering Strategic Alternatives

Market Watch

Weekly Market Review – February 8, 2025

Weekly Market Review – February 1, 2025

Weekly Market Review – January 25, 2025

Weekly Market Review – January 18, 2024

Weekly Market Review – January 11, 2025

Bio Business News

Swiss ADC Biotech Takes SPAC Track to NASDAQ

Pharma’s Biggest Golden Parachutes

New technique expands tissues so hundreds of biomolecules can be seen inside cells

World News

CT scans could cause 5% of cancers, study finds; experts note uncertainty

Vaccine expert worries child measles deaths are being ‘normalized’

Getting older doesn’t have to mean getting stiffer. 5 ways to keep mobile as you age